Ticker Appearances
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Friday the 13th Reversal should prove short-lived into next week
US EQUITY MARKETS LOOK TO HAVE BOTTOMED ON 10/3 AND ARE LIKELY TO PROGRESS OFF OCTOBER LOWS IN A TWO-STEPS FORWARD, ONE STEP BACKWARDS TYPE...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Friday the 13th Reversal should prove short-lived into next week
US EQUITY MARKETS LOOK TO HAVE BOTTOMED ON 10/3 AND ARE LIKELY TO PROGRESS OFF OCTOBER LOWS IN A TWO-STEPS FORWARD, ONE STEP BACKWARDS TYPE...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 2 [max_usage] => 2 [max_usage_crypto] => 2 )
